WHO/Nazik Armenakyan
© Credits

Antimicrobial resistance

    Overview

    Antimicrobial resistance (AMR) is the resistance of a microorganism to an antimicrobial medicine to which it was previously sensitive. It develops when a microorganism mutates or acquires a resistance gene.

    Resistant organisms (including bacteria, viruses, fungi, protozoa and helminths) are able to withstand attack by antimicrobial medicines such as antibiotics, antivirals and antimalarials, so that standard treatments become ineffective and infections persist and may spread to other people.

    Publications

    All →
    Action against antimicrobial resistance requires a One Health approach

    Why pay attention to One Health? One Health is an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals...

    Action against antimicrobial resistance and noncommunicable diseases

    Four main NCDs – cardiovascular diseases, cancer, diabetes and chronic respiratory diseases – account for nearly 75% of deaths in the WHO European...

    People-centred approach to tackling antimicrobial resistance: key principle of the Roadmap on antimicrobial resistance for the WHO European Region 2023–2030

    A people-centred approach to tackling antimicrobial resistance (‎AMR)‎ was developed to support countries in their implementation of the recently...

    Prevention and control of antimicrobial resistance in the food chain: guidance for food safety authorities in Europe

    In 2011, the WHO Regional Office for Europe launched the publication Tackling antibiotic resistance from a food safety perspective in Europe. The publication...